TL;DR
This study reveals that advanced maternal age (AMA) significantly alters the decidual microenvironment, leading to fibrosis and impaired decidualization. A novel PRR15-TGF-β signaling axis is identified as a key driver of these age-related changes, highlighting the decidua as a critical factor in reproductive decline.
What Problem Does This Paper Address?
Advanced maternal age (AMA) is a known risk factor for adverse pregnancy outcomes. While declining oocyte quality has been a primary focus, the role of the maternal uterine environment, specifically the decidua, in AMA-associated reproductive challenges remains less understood. This paper aims to characterize the decidual microenvironment in women of AMA to identify key pathological changes and regulatory pathways that contribute to age-related reproductive decline.
Methods
The researchers employed a multi-pronged approach:
- Single-cell RNA sequencing (scRNA-seq): This was the core technique, used to generate a high-resolution transcriptomic atlas of the first-trimester decidua from both AMA and control (CTR) individuals. This allowed for the identification of distinct cell populations and their gene expression profiles.
- Histology and Immunostaining (IHC, IF): Standard techniques were used to visualize tissue structure, fibrosis (Masson's trichrome, Sirius Red), and the expression of key proteins like IGFBP1 and alpha-SMA.
- Cell and Organoid Culture: Primary stromal cells and endometrial epithelial organoids (EEOs) were cultured to study decidualization and epithelial function in vitro.
- Gene Manipulation: Lentiviral-mediated knockdown (KD) and overexpression (OE) of the PRR15 gene were performed in stromal cells to investigate its functional role.
- Molecular Biology Assays: Western blot, RT-qPCR, and ELISA were used to quantify protein and mRNA levels, and assess signaling pathway activation.
- Bioinformatic Analysis: This included standard pipelines for scRNA-seq data processing, dimensionality reduction (UMAP), clustering (Louvain, Leiden), differential gene expression (DEG) analysis, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, and trajectory inference (Slingshot) and cell-cell communication analysis (CellChat).
Datasets
- Human Decidual Tissues: Samples were collected from women of advanced maternal age (AMA, ≥35 years) and control reproductive age (CTR, 22-30 years) undergoing first-trimester surgical termination.
- Discovery Cohort: 3 AMA and 3 CTR individuals for scRNA-seq.
- Validation Cohort: 6 AMA and 6 CTR individuals for histological and functional validation.
- scRNA-seq Data: Raw single-cell sequence data has been deposited in NCBI's Gene Expression Omnibus (GEO) under accession number GSE305088.
Key Insights and Ideas
- Decidua as a Key Player: The study strongly suggests that the decidual microenvironment, not just oocyte quality, is a critical determinant of reproductive success in AMA.
- The PRR15-TGF-β Axis: A novel signaling pathway involving PRR15 and TGF-β is identified as central to age-related decidual dysfunction. PRR15 acts as a negative regulator of TGF-β signaling, and its loss in AMA leads to uncontrolled TGF-β activation.
- Early Onset of Fibrosis: AMA-associated uterine fibrosis begins as early as the first trimester, shifting the focus to maternal factors rather than solely oocyte-related issues.
- Cellular Dysregulation: AMA decidua exhibits a complex pattern of cellular dysfunction, including:
- Fibroblast-to-Myofibroblast Transition (FMT): Fibroblasts become hyperactivated, leading to excessive extracellular matrix (ECM) deposition.
- Failed Mesenchymal-to-Epithelial Transition (MET): This is crucial for decidualization and is impaired in AMA.
- Pathogenic Epithelial-to-Mesenchymal Transition (EMT): Epithelial cells undergo EMT, amplifying fibrosis.
- Immune Cell Reprogramming: Immune cells adopt pro-fibrotic transcriptional signatures and show reduced supportive functions.
- Decidual Stromal Cell (DSC) Arrest: DSCs fail to properly differentiate, getting stuck in an intermediate state (DSC1) and not reaching the mature, decidualized state (DSC2).
Key Results
- Histological Evidence: AMA decidua showed impaired glandular architecture, reduced gland density, nuclear pleomorphism in stromal cells, and extensive, disorganized collagen deposition (fibrosis).
- Functional Impairment: Primary stromal cells from AMA individuals exhibited impaired decidualization and reduced induction of key decidualization markers. Endometrial epithelial organoids (EEOs) from AMA also showed reduced formation efficiency and impaired response to hormonal stimulation.
- scRNA-seq Atlas: Identified 12 distinct cell populations in the decidua. Global DEG analysis revealed a significant shift towards ECM organization, collagen fibril organization, and focal adhesion pathways in AMA, indicating a pro-fibrotic program.
- Fibroblast Subsets: Three fibroblast subsets were identified. While proportions didn't differ, AMA fibroblasts showed altered transcriptional states, with increased matrix production and suppressed immune chemotaxis.
- DSC Subsets: Four DSC subsets were identified. AMA DSCs showed elevated 'Migration', 'TGF-β Signalling', and 'Collagen Production' scores, and a diminished 'Decidualisation' score.
- PRR15 Deficiency: Knockdown of PRR15 in stromal cells severely impaired decidual competence, leading to increased TGF-β/SMAD signaling, enhanced fibrosis markers (Vimentin, COL6A1), and reduced IGFBP1.
- Immune Cell Signatures: Decidual macrophages and NK cells in AMA showed pro-fibrotic signatures and impaired immune surveillance pathways.
- Cell-Cell Communication: A global reduction in interaction networks and strength was observed in AMA decidua, with dysregulation of key pathways like PRL, CD99, SPP1, and GALECTIN.
Limitations and Future Work
- Small Discovery Cohort: The initial scRNA-seq discovery cohort was small (n=3 per group), limiting statistical power and potentially susceptible to inter-individual variability. Validation in a larger cohort (n=6 per group) was performed.
- Limited Patient Diversity: The study included patients with a narrow BMI range and some with prior miscarriages, which might confound age-related effects. Future studies with more diverse cohorts are needed.
- shRNA for PRR15: While functional experiments strongly support the PRR15-TGF-β axis, the validation relied on shRNA. CRISPR-Cas9-mediated knockout is suggested for definitive target specificity confirmation.
- PRR15-SMAD Link: The precise molecular interaction linking PRR15 loss to SMAD phosphorylation needs further elucidation.
- Immune Cell Function: The pro-fibrotic function of immune cells is inferred from transcriptomics. Functional assays (co-culture) are needed to confirm matrix deposition and cytokine secretion.
- Spatial Context: Cell-cell communication analysis is based on transcriptomic inference and lacks spatial context. Integrating spatial transcriptomics or multiplex immunofluorescence is recommended.
Summary updated